Minocycline Hydrochloride

Drug Usage Statistics, United States, 2004 - 2014

Number of Prescriptions Over Time (2004 - 2014)

Rank of Top Drugs Over Time

"Rank" refers to the frequency that a given medication is prescribed within a calendar year compared to all other medications. A rank of "4" would indicate that the medication was the fourth most commonly prescribed medication.

Year Rank Change
2004 184 -
2005 201  17
2006 211  10
2007 214  3
2008 202  12
2009 163  39
Year Rank Change
2010 222  59
2011 219  3
2012 229  10
2013 182  47
2014 224  42

Patient Out-Of-Pocket Cost Over Time (2004 - 2014)

"Out-of-pocket" cost refers to the payment made by the patient (either cash price or the copay amount). This value does not include reimbursement from a third party payer (eg, Medicare or private insurance) and does not represent the total drug cost.

Usage Statistics of Related Drugs

Drug Name Total Prescriptions (2014)
Minocycline Hydrochloride (this drug) 2,696,066

Drug Synonyms

Drug synonyms are used during the sanitation and standardization process of "cleaning" the original data source (MEPS). Occassionally, brand names may be listed below that are no longer on the market or are very infrequently used.

Brand Name Synonyms
  • Arestin
  • Dynacin
  • Minocin
  • Solodyn
  • Ximino
Generic Drug Synonyms and Salts
  • Minocycline Hydrochloride

FDA Approval Information

Established Pharmacologic Class (EPC): Tetracycline-class Drug
Initial FDA approval date: Prior to January 1, 1982
First FDA applicant: Triax Pharmaceuticals Llc
First dosage form: Capsule (oral)

Prescription data source: Medical Expenditure Panel Survey (MEPS) 2004-2014. Agency for Healthcare Research and Quality (AHRQ), Rockville, MD. ClinCalc DrugStats Database version 17.0. Read more about the ClinCalc DrugStats database.

Search

Related Links

Follow Us!

New and Popular

Loading...

Open Menu

Cite This Page

Show AMA citation

Which of these drugs causes acute kidney injury? The Top 250 Drugs by ClinCalc Academy
©2017 - ClinCalc LLC. All rights reserved.
Disclaimer - Privacy Policy - Contact Us
Updated Mar 4, 2017
Back to Top
Top